141566-34-9

Upstream product

• 86534-97-6 (2S,3S,4S,5R,6S)-7-hydroxy-3,5-(isopropylidenedioxy)-2,4,6-trimethylheptyl p-toluenesulfonate 
• 116661-41-7 (2S,4R,5R)-1-(benzyloxy)-5-hydroxy-2,4,6-trimethylhept-6-en-3-one 
• 128146-35-0 (2S,3S,4S,5R,6E)-1-(benzyloxy)-2,4-dimethyl-6-octene-3,5-diol 
• 141611-63-4 (2S,4S,5R,6E)-1-(benzyloxy)-5-hydroxy-2,4-dimethyl-6-octen-3-one 
• 160691-36-1 (2S,3S,4S,5R,6S)-7-(benzyloxy)-3,5-(isopropylidenedioxy)-2,4,6-trimethylheptyl p-toluenesulfonate 
• 160691-33-8 (2E,4R,5S,6S,7S,8R)-8-<(benzyloxy)methoxy>-4,6-bis(tert-butyldimethylsiloxy)-5,7-dimethyl-7-nonene 
• 160691-35-0 (2S,3S,4S,5R,6S)-7-(benzyloxy)-3,5-dihydroxy-2,4,6-trimethylheptyl p-toluenesulfonate 
• 160691-31-6 (2E,4R,5S,6S,7S)-8-(benzyloxy)-4,6-bis(tert-butyldimethylsiloxy)-5,7-dimethyl-2-octene 
• 141566-32-7 (2R,3R,4S,5R,6E)-3,5-bis(tert-butyldimethylsiloxy)-2,4-dimethyl-6-octenal 
• 141566-31-6 (2R,3S,4S,5S,6R,7E)-4,6-bis(tert-butyldimethylsiloxy)-3,5-dimethyl-7-nonen-2-ol 
• 160691-32-7 (2S,3S,4S,5R,6E)-3,5-bis(tert-butyldimethylsiloxy)-2,4-dimethyl-6-octene-1-ol 
• 140925-44-6 (2S,3S,4R,5R,6S)-7-(benzyloxy)-2,4,6-trimethyl-1,3,5-heptanetriol 
• 86534-98-7 (SRS,2S,3R,4S,5R,6R)-3,5-(isopropylidenedioxy)-2,4,6-trimethyl-7-(phenylsulfinyl)heptan-1-ol 
• 141566-33-8 (2S,3R,4S,5S,6R)-6-<(benzyloxy)methoxy>-2,4-bis(tert-butyldimethylsiloxy)-3,5-dimethylheptanal 

Downstream Products

• 160691-42-9 C₄₁H₆₉Cl₃O₉Si₂ 
• 141566-35-0 (R)-2-{(4S,5R,6S)-6-[(1S,4S,5R,6S,7S,8R)-8-Benzyloxymethoxy-4,6-bis-(tert-butyl-dimethyl-silanyloxy)-1,5,7-trimethyl-3-oxo-nonyl]-2,2,5-trimethyl-[1,3]dioxan-4-yl}-propionic acid 

Relevant academic research and scientific papers

Studies in macrolide synthesis: A stereocontrolled synthesis of a (9S)-macrolide intermediate for oleandomycin using chiral boron reagents

The (9S)-macrolide 1 (P = TBS) was prepared in 14 stpes (5% yield) with 63% overall ds starting from the ethyl ketone (S)-2. The C1-C7 and C8-C13 segments, 3 and 4, were obtained via boron enolate aldol reaction